Share Price and Basic Stock Data
Last Updated: December 19, 2025, 8:22 pm
| PEG Ratio | -0.90 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cyient DLM Ltd operates in the electronics equipment and components sector, an industry marked by rapid technological advancements and evolving customer needs. The company reported sales of ₹832 Cr for FY 2023, a substantial increase from ₹721 Cr in FY 2022. This upward trajectory is evident in the quarterly figures as well—sales rose from ₹170 Cr in September 2022 to ₹292 Cr by September 2023. However, the latest quarter, June 2025, saw a dip to ₹206 Cr, indicating potential seasonality or other operational challenges. The trailing twelve months (TTM) revenue stood at ₹1,140 Cr, which showcases a consistent demand for the company’s offerings, albeit with fluctuations in quarterly performance that investors should monitor closely.
Profitability and Efficiency Metrics
Profitability metrics reflect a mixed yet generally positive outlook for Cyient DLM. The operating profit margin (OPM) stood at 12% for FY 2023, slightly lower than the 12% recorded in FY 2022, indicating stable operational efficiency. However, the OPM fluctuated over the quarters, peaking at 17% in March 2025 but dropping to 12% by September 2025. Net profit for FY 2025 reached ₹77 Cr, an increase from ₹61 Cr in FY 2024, showcasing a solid bottom line. The return on equity (ROE) at 8.23% and return on capital employed (ROCE) at 12.3% seem reasonable for the sector, but they suggest that there is room for improvement in generating returns relative to equity and capital employed.
Balance Sheet Strength and Financial Ratios
Cyient DLM’s balance sheet presents a relatively comfortable picture, with total borrowings at ₹103 Cr against reserves of ₹894 Cr, indicating a strong equity buffer. The debt-to-equity ratio stood at 0.25, suggesting that the company is not overly leveraged, which is a positive sign for risk-averse investors. The interest coverage ratio (ICR) of 4.35x indicates that the company can comfortably cover its interest obligations, further enhancing its financial stability. However, the cash conversion cycle (CCC) of 175 days raises some concerns about liquidity and operational efficiency, suggesting that the company may take longer than average to convert its investments in inventory and receivables into cash.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cyient DLM reveals a diverse mix of stakeholders, with promoters holding 52.12% as of September 2025. This is a decline from earlier levels, which could signal a potential shift in management strategy or investor sentiment. Foreign institutional investors (FIIs) have reduced their stake to 2.19%, while domestic institutional investors (DIIs) have increased their holdings to 28.74%. The public shareholding stands at 16.94%, reflecting a growing interest among retail investors. The increase in DII holdings suggests a level of confidence in the company’s prospects, yet the decline in promoter holdings could raise questions about long-term strategic direction.
Outlook, Risks, and Final Insight
Looking ahead, Cyient DLM faces a dual-edged sword of opportunity and risk. On one hand, the electronics sector is poised for growth, driven by advancements in technology and increasing demand for components. However, the fluctuating quarterly sales and profit margins indicate potential volatility that investors should be wary of. Additionally, the company’s reliance on maintaining a manageable cash conversion cycle is critical; prolonged cycles could strain liquidity. Investors may want to keep an eye on the evolving shareholding pattern as well, particularly the declining promoter stake, which could signal changing dynamics within the company. In summary, while Cyient DLM has a solid foundation and promising growth prospects, careful monitoring of its operational efficiency and financial health will be essential for making informed investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Incap Ltd | 42.8 Cr. | 83.5 | 161/70.0 | 48.1 | 32.6 | 1.20 % | 7.61 % | 4.95 % | 10.0 |
| Gujarat Poly Electronics Ltd | 53.1 Cr. | 62.1 | 112/62.0 | 12.3 | 16.9 | 0.00 % | 12.5 % | 20.8 % | 10.0 |
| Cosmo Ferrites Ltd | 198 Cr. | 165 | 385/136 | 20.1 | 0.00 % | 0.74 % | 20.5 % | 10.0 | |
| BCC Fuba India Ltd | 274 Cr. | 179 | 219/87.8 | 58.1 | 16.9 | 0.00 % | 18.7 % | 17.4 % | 10.0 |
| PG Electroplast Ltd | 16,597 Cr. | 582 | 1,055/465 | 65.2 | 102 | 0.04 % | 19.4 % | 14.9 % | 1.00 |
| Industry Average | 3,749.00 Cr | 1,240.84 | 78.76 | 165.67 | 0.21% | 11.17% | 15.55% | 7.92 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 170 | 214 | 277 | 217 | 292 | 321 | 362 | 258 | 389 | 357 | 340 | 206 | 236 |
| Expenses | 146 | 194 | 245 | 197 | 268 | 292 | 324 | 238 | 358 | 328 | 283 | 181 | 208 |
| Operating Profit | 24 | 21 | 32 | 20 | 24 | 29 | 38 | 20 | 32 | 30 | 58 | 25 | 27 |
| OPM % | 14% | 10% | 12% | 9% | 8% | 9% | 11% | 8% | 8% | 8% | 17% | 12% | 12% |
| Other Income | -1 | -0 | -1 | 1 | 9 | 9 | 8 | 9 | 7 | 8 | 3 | 4 | 3 |
| Interest | 8 | 8 | 9 | 9 | 8 | 8 | 9 | 8 | 11 | 10 | 7 | 7 | 5 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 |
| Profit before tax | 10 | 7 | 17 | 7 | 20 | 25 | 31 | 14 | 21 | 21 | 47 | 15 | 18 |
| Tax % | 30% | 21% | 27% | 23% | 26% | 25% | 26% | 25% | 26% | 26% | 25% | 26% | 26% |
| Net Profit | 7 | 6 | 13 | 5 | 15 | 18 | 23 | 11 | 16 | 16 | 35 | 11 | 14 |
| EPS in Rs | 24.17 | 1.08 | 2.38 | 0.94 | 1.85 | 2.33 | 2.87 | 1.35 | 1.96 | 1.96 | 4.40 | 1.42 | 1.71 |
Last Updated: October 16, 2025, 1:43 pm
Below is a detailed analysis of the quarterly data for Cyient DLM Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 236.00 Cr.. The value appears strong and on an upward trend. It has increased from 206.00 Cr. (Jun 2025) to 236.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Sep 2025, the value is 208.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.00 Cr. (Jun 2025) to 208.00 Cr., marking an increase of 27.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Jun 2025) to 27.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 12.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 12.00%.
- For Other Income, as of Sep 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Jun 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Jun 2025) to 5.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 7.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Jun 2025) to 18.00 Cr., marking an increase of 3.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Jun 2025) to 14.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.71. The value appears strong and on an upward trend. It has increased from 1.42 (Jun 2025) to 1.71, marking an increase of 0.29.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:28 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 480 | 457 | 628 | 721 | 832 | 1,192 | 1,345 | 1,140 |
| Expenses | 462 | 443 | 582 | 636 | 744 | 1,081 | 1,206 | 1,000 |
| Operating Profit | 19 | 14 | 46 | 84 | 88 | 111 | 139 | 140 |
| OPM % | 4% | 3% | 7% | 12% | 11% | 9% | 10% | 12% |
| Other Income | 2 | 8 | 9 | 8 | 6 | 28 | 28 | 19 |
| Interest | 14 | 18 | 21 | 22 | 32 | 34 | 36 | 29 |
| Depreciation | 8 | 11 | 18 | 19 | 19 | 22 | 28 | 29 |
| Profit before tax | -1 | -7 | 16 | 51 | 43 | 82 | 103 | 101 |
| Tax % | -43% | -7% | 24% | 22% | 26% | 25% | 26% | |
| Net Profit | -1 | -7 | 12 | 40 | 32 | 61 | 77 | 75 |
| EPS in Rs | -5.78 | -49.01 | 86.39 | 291.15 | 6.00 | 7.72 | 9.67 | 9.49 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -600.00% | 271.43% | 233.33% | -20.00% | 90.62% | 26.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | 871.43% | -38.10% | -253.33% | 110.62% | -64.40% |
Cyient DLM Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
Last Updated: September 5, 2025, 2:30 am
Balance Sheet
Last Updated: October 16, 2025, 1:43 pm
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 53 | 79 | 79 | 79 |
| Reserves | 34 | 24 | 36 | 76 | 145 | 830 | 876 | 894 |
| Borrowings | 160 | 308 | 279 | 337 | 356 | 192 | 196 | 103 |
| Other Liabilities | 271 | 260 | 328 | 363 | 551 | 502 | 370 | 413 |
| Total Liabilities | 466 | 593 | 645 | 777 | 1,105 | 1,603 | 1,521 | 1,490 |
| Fixed Assets | 48 | 106 | 186 | 172 | 161 | 192 | 203 | 200 |
| CWIP | 1 | 77 | 2 | 3 | 1 | 1 | 6 | 4 |
| Investments | 0 | 0 | 0 | 0 | 90 | 66 | 156 | 153 |
| Other Assets | 417 | 410 | 457 | 601 | 853 | 1,344 | 1,156 | 1,133 |
| Total Assets | 466 | 593 | 645 | 777 | 1,105 | 1,603 | 1,521 | 1,490 |
Below is a detailed analysis of the balance sheet data for Cyient DLM Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 79.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 79.00 Cr..
- For Reserves, as of Sep 2025, the value is 894.00 Cr.. The value appears strong and on an upward trend. It has increased from 876.00 Cr. (Mar 2025) to 894.00 Cr., marking an increase of 18.00 Cr..
- For Borrowings, as of Sep 2025, the value is 103.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 196.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 93.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 413.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 370.00 Cr. (Mar 2025) to 413.00 Cr., marking an increase of 43.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,490.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,521.00 Cr. (Mar 2025) to 1,490.00 Cr., marking a decrease of 31.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 200.00 Cr.. The value appears to be declining and may need further review. It has decreased from 203.00 Cr. (Mar 2025) to 200.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 153.00 Cr.. The value appears to be declining and may need further review. It has decreased from 156.00 Cr. (Mar 2025) to 153.00 Cr., marking a decrease of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,133.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,156.00 Cr. (Mar 2025) to 1,133.00 Cr., marking a decrease of 23.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,490.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,521.00 Cr. (Mar 2025) to 1,490.00 Cr., marking a decrease of 31.00 Cr..
Notably, the Reserves (894.00 Cr.) exceed the Borrowings (103.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -141.00 | -294.00 | -233.00 | -253.00 | -268.00 | -81.00 | -57.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 91 | 44 | 132 | 77 | 71 | 69 | 81 |
| Inventory Days | 170 | 223 | 115 | 181 | 240 | 184 | 175 |
| Days Payable | 92 | 105 | 140 | 129 | 161 | 123 | 82 |
| Cash Conversion Cycle | 170 | 161 | 106 | 129 | 150 | 131 | 175 |
| Working Capital Days | 52 | -107 | -48 | -25 | -32 | 76 | 108 |
| ROCE % | 4% | 11% | 20% | 16% | 14% | 12% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Power & Infra Fund | 2,217,149 | 1.3 | 95.15 | 2,803,867 | 2025-12-08 04:23:34 | -20.93% |
| Nippon India Multi Cap Fund | 1,320,000 | 0.11 | 56.65 | N/A | N/A | N/A |
| Nippon India Small Cap Fund | 1,256,139 | 0.08 | 53.91 | 902,150 | 2025-10-16 07:28:50 | 39.24% |
| Aditya Birla Sun Life Value Fund | 1,077,494 | 0.73 | 46.24 | N/A | N/A | N/A |
| Aditya Birla Sun Life Digital India Fund | 1,010,863 | 0.89 | 43.38 | 1,020,877 | 2025-12-08 04:23:34 | -0.98% |
| ICICI Prudential Technology Fund | 988,132 | 0.27 | 42.41 | N/A | N/A | N/A |
| DSP India T.I.G.E.R. Fund | 776,839 | 0.62 | 33.34 | N/A | N/A | N/A |
| Aditya Birla Sun Life Equity Hybrid 95 Fund | 717,494 | 0.4 | 30.79 | N/A | N/A | N/A |
| Nippon India Retirement Fund - Wealth Creation Scheme | 647,042 | 0.86 | 27.77 | 637,176 | 2025-10-16 07:28:50 | 1.55% |
| ICICI Prudential Multi Asset Fund | 427,426 | 0.02 | 18.34 | 404,620 | 2025-12-15 01:38:03 | 5.64% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.58 | 8.42 | 7.75 |
| Diluted EPS (Rs.) | 8.56 | 8.39 | 7.75 |
| Cash EPS (Rs.) | 12.88 | 10.53 | 9.67 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 119.72 | 114.62 | 37.43 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.72 | 114.62 | 37.43 |
| Revenue From Operations / Share (Rs.) | 191.62 | 150.29 | 157.38 |
| PBDIT / Share (Rs.) | 20.59 | 17.51 | 17.80 |
| PBIT / Share (Rs.) | 16.30 | 14.69 | 14.13 |
| PBT / Share (Rs.) | 11.57 | 10.36 | 8.16 |
| Net Profit / Share (Rs.) | 8.58 | 7.72 | 6.00 |
| NP After MI And SOA / Share (Rs.) | 8.58 | 7.72 | 6.00 |
| PBDIT Margin (%) | 10.74 | 11.64 | 11.30 |
| PBIT Margin (%) | 8.50 | 9.77 | 8.97 |
| PBT Margin (%) | 6.03 | 6.89 | 5.18 |
| Net Profit Margin (%) | 4.47 | 5.13 | 3.81 |
| NP After MI And SOA Margin (%) | 4.47 | 5.13 | 3.81 |
| Return on Networth / Equity (%) | 7.17 | 6.73 | 16.03 |
| Return on Capital Employeed (%) | 11.14 | 10.95 | 20.75 |
| Return On Assets (%) | 4.01 | 3.81 | 2.87 |
| Long Term Debt / Equity (X) | 0.15 | 0.08 | 0.50 |
| Total Debt / Equity (X) | 0.25 | 0.14 | 1.59 |
| Asset Turnover Ratio (%) | 0.92 | 0.88 | 0.00 |
| Current Ratio (X) | 2.40 | 2.46 | 1.13 |
| Quick Ratio (X) | 1.33 | 1.60 | 0.55 |
| Inventory Turnover Ratio (X) | 2.10 | 2.13 | 0.00 |
| Interest Coverage Ratio (X) | 4.35 | 4.04 | 2.99 |
| Interest Coverage Ratio (Post Tax) (X) | 2.81 | 2.78 | 2.01 |
| Enterprise Value (Cr.) | 3581.45 | 5308.59 | 0.00 |
| EV / Net Operating Revenue (X) | 2.36 | 4.45 | 0.00 |
| EV / EBITDA (X) | 21.93 | 38.24 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 2.39 | 4.79 | 0.00 |
| Price / BV (X) | 3.82 | 6.28 | 0.00 |
| Price / Net Operating Revenue (X) | 2.39 | 4.79 | 0.00 |
| EarningsYield | 0.01 | 0.01 | 0.00 |
After reviewing the key financial ratios for Cyient DLM Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.58. This value is within the healthy range. It has increased from 8.42 (Mar 24) to 8.58, marking an increase of 0.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.56. This value is within the healthy range. It has increased from 8.39 (Mar 24) to 8.56, marking an increase of 0.17.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.88. This value is within the healthy range. It has increased from 10.53 (Mar 24) to 12.88, marking an increase of 2.35.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.72. It has increased from 114.62 (Mar 24) to 119.72, marking an increase of 5.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.72. It has increased from 114.62 (Mar 24) to 119.72, marking an increase of 5.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 191.62. It has increased from 150.29 (Mar 24) to 191.62, marking an increase of 41.33.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 20.59. This value is within the healthy range. It has increased from 17.51 (Mar 24) to 20.59, marking an increase of 3.08.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.30. This value is within the healthy range. It has increased from 14.69 (Mar 24) to 16.30, marking an increase of 1.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.57. This value is within the healthy range. It has increased from 10.36 (Mar 24) to 11.57, marking an increase of 1.21.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.58. This value is within the healthy range. It has increased from 7.72 (Mar 24) to 8.58, marking an increase of 0.86.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.58. This value is within the healthy range. It has increased from 7.72 (Mar 24) to 8.58, marking an increase of 0.86.
- For PBDIT Margin (%), as of Mar 25, the value is 10.74. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 10.74, marking a decrease of 0.90.
- For PBIT Margin (%), as of Mar 25, the value is 8.50. This value is below the healthy minimum of 10. It has decreased from 9.77 (Mar 24) to 8.50, marking a decrease of 1.27.
- For PBT Margin (%), as of Mar 25, the value is 6.03. This value is below the healthy minimum of 10. It has decreased from 6.89 (Mar 24) to 6.03, marking a decrease of 0.86.
- For Net Profit Margin (%), as of Mar 25, the value is 4.47. This value is below the healthy minimum of 5. It has decreased from 5.13 (Mar 24) to 4.47, marking a decrease of 0.66.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.47. This value is below the healthy minimum of 8. It has decreased from 5.13 (Mar 24) to 4.47, marking a decrease of 0.66.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.17. This value is below the healthy minimum of 15. It has increased from 6.73 (Mar 24) to 7.17, marking an increase of 0.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.14. This value is within the healthy range. It has increased from 10.95 (Mar 24) to 11.14, marking an increase of 0.19.
- For Return On Assets (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 5. It has increased from 3.81 (Mar 24) to 4.01, marking an increase of 0.20.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has increased from 0.08 (Mar 24) to 0.15, marking an increase of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 0.25, marking an increase of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.92. It has increased from 0.88 (Mar 24) to 0.92, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 2.40. This value is within the healthy range. It has decreased from 2.46 (Mar 24) to 2.40, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.33, marking a decrease of 0.27.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.10. This value is below the healthy minimum of 4. It has decreased from 2.13 (Mar 24) to 2.10, marking a decrease of 0.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.35. This value is within the healthy range. It has increased from 4.04 (Mar 24) to 4.35, marking an increase of 0.31.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.81. This value is below the healthy minimum of 3. It has increased from 2.78 (Mar 24) to 2.81, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,581.45. It has decreased from 5,308.59 (Mar 24) to 3,581.45, marking a decrease of 1,727.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.36. This value is within the healthy range. It has decreased from 4.45 (Mar 24) to 2.36, marking a decrease of 2.09.
- For EV / EBITDA (X), as of Mar 25, the value is 21.93. This value exceeds the healthy maximum of 15. It has decreased from 38.24 (Mar 24) to 21.93, marking a decrease of 16.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 4.79 (Mar 24) to 2.39, marking a decrease of 2.40.
- For Price / BV (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has decreased from 6.28 (Mar 24) to 3.82, marking a decrease of 2.46.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 4.79 (Mar 24) to 2.39, marking a decrease of 2.40.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cyient DLM Ltd:
- Net Profit Margin: 4.47%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.14% (Industry Average ROCE: 11.17%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.17% (Industry Average ROE: 15.55%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.81
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 44.4 (Industry average Stock P/E: 59.07)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.47%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Electronics - Equipment/Components | Plot No. 5G, Survey No. 99/1, Hyderabad Telangana 500108 | company.secretary@cyientdlm.com http://www.cyientdlm.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Krishna Bodanapu | Non Executive Chairman |
| Mr. Rajendra Velagapudi | Managing Director |
| Mr. B V R Mohan Reddy | Non Executive Director |
| Ms. Vanitha Datla | Independent Director |
| Mr. Jehangir Ardeshir | Independent Director |
| Mr. Muralidhar Yadama | Independent Director |
| Dr. Ajay Kumar | Independent Director |
| Mr. Madan Pillutla | Independent Director |
FAQ
What is the intrinsic value of Cyient DLM Ltd?
Cyient DLM Ltd's intrinsic value (as of 19 December 2025) is 366.76 which is 12.88% lower the current market price of 421.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,346 Cr. market cap, FY2025-2026 high/low of 697/350, reserves of ₹894 Cr, and liabilities of 1,490 Cr.
What is the Market Cap of Cyient DLM Ltd?
The Market Cap of Cyient DLM Ltd is 3,346 Cr..
What is the current Stock Price of Cyient DLM Ltd as on 19 December 2025?
The current stock price of Cyient DLM Ltd as on 19 December 2025 is 421.
What is the High / Low of Cyient DLM Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cyient DLM Ltd stocks is 697/350.
What is the Stock P/E of Cyient DLM Ltd?
The Stock P/E of Cyient DLM Ltd is 44.4.
What is the Book Value of Cyient DLM Ltd?
The Book Value of Cyient DLM Ltd is 123.
What is the Dividend Yield of Cyient DLM Ltd?
The Dividend Yield of Cyient DLM Ltd is 0.00 %.
What is the ROCE of Cyient DLM Ltd?
The ROCE of Cyient DLM Ltd is 12.3 %.
What is the ROE of Cyient DLM Ltd?
The ROE of Cyient DLM Ltd is 8.23 %.
What is the Face Value of Cyient DLM Ltd?
The Face Value of Cyient DLM Ltd is 10.0.